Back to Trades
Total Value
$0
Filing Date
Jun 4, 2026
1 transactions
Trade Summary
On Jun 3, 2026, BARKER SAM L, Director, reported $0 of LEXICON PHARMACEUTICALS, INC. (LXRX) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- LEXICON PHARMACEUTICALS, INC.
- Ticker Symbol
- LXRX
- CIK
- 0001062822
Insider Information
- Name
- BARKER SAM L
- Role
- Director
- Location
- THE WOODLANDS, TX
Filing Details
- Filing Date
- Jun 4, 2026
- Transaction Date
- Jun 3, 2026
- Accession Number
- 0001062822-26-000104
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | 89,312 | — | Exercise | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | LXRX derivative | 89,312 | — | Exercise | — |
Want live alerts when BARKER SAM L trades again?
Download Insider Trades to track LXRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
- (F2)Each restricted stock unit represents a contingent right to receive one share of common stock.